[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f5kHGyE2O6qAwbKvGT07HDE7GEMz147ewkxYdl38WSG8":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":7,"truncated":8,"activeTrials":9,"phase3Count":10,"totalEnrollment":11,"activePrograms":12,"nonDrugCount":13,"topConditions":14,"upcomingReadouts":35,"phaseBuckets":83,"rows":90},"Monash University",[4,6],"Monash University Malaysia",92,false,32,12,365380,27,65,[15,18,21,23,26,28,30,33],{"name":16,"count":17},"Heart Failure",6,{"name":19,"count":20},"Myeloma",4,{"name":22,"count":20},"Leukemia",{"name":24,"count":25},"Non Hodgkin's Lymphoma",3,{"name":27,"count":25},"Cancer",{"name":29,"count":25},"Insulin Resistance",{"name":31,"count":32},"Aging",2,{"name":34,"count":32},"PreDiabetes",[36,41,46,51,56,61,65,69,73,78],{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT04676204","Relationship Between Oral DMT Burden and Adherence in MS","2025-11-19","Cladribine",{"nctId":42,"briefTitle":43,"date":44,"intervention":45},"NCT02099123","A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)","2025-12","Atorvastatin",{"nctId":47,"briefTitle":48,"date":49,"intervention":50},"NCT05556720","Bringing Optimised COVID-19 Vaccine Schedules To ImmunoCompromised Populations (BOOST-IC): an Adaptive Randomised Controlled Clinical Trial","2026-06-30","Pfizer Bivalent COVID-19 Vaccine",{"nctId":52,"briefTitle":53,"date":54,"intervention":55},"NCT05586750","Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy","2026-09","Atorvastatin 40 Mg Oral",{"nctId":57,"briefTitle":58,"date":59,"intervention":60},"NCT07202065","Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)","2027-03-31","Immune Globulin Intravenous",{"nctId":62,"briefTitle":63,"date":59,"intervention":64},"NCT07202091","Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)","Trimethoprim Sulfamethoxazole",{"nctId":66,"briefTitle":67,"date":59,"intervention":68},"NCT07202052","Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)","Intravenous immunoglobulin",{"nctId":70,"briefTitle":71,"date":59,"intervention":72},"NCT07202078","Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)","Trimethoprim \u002F Sulfamethoxazole",{"nctId":74,"briefTitle":75,"date":76,"intervention":77},"NCT05678621","Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension","2027-04","trimethoprim-sulfamethoxazole",{"nctId":79,"briefTitle":80,"date":81,"intervention":82},"NCT05651347","Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction","2027-04-30","Melatonin 10 MG",[84,85,86,87,88,89],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[91,120,144,176,194,212,239,257,288,312,340,358,376,394,423,446,464,482,506,524,542,568,597,615,633,651,669,687,712,730,748,775,800,827,852,878,902,926,944,970,996,1022,1047],{"intervention":55,"totalTrials":92,"cells":93},1,{"EARLY_PHASE1":94,"PHASE1":97,"PHASE2":99,"PHASE3":101,"PHASE4":103,"NA":118},{"trials":95,"activeCount":96},[],0,{"trials":98,"activeCount":96},[],{"trials":100,"activeCount":96},[],{"trials":102,"activeCount":96},[],{"trials":104,"activeCount":92,"soonestReadout":54},[105],{"nctId":52,"briefTitle":53,"status":106,"phases":107,"primaryCompletion":54,"completion":54,"start":108,"enrollment":109,"conditions":110,"interventions":117},"ACTIVE_NOT_RECRUITING",[88],"2019-09-19",341,[111,112,113,114,115,31,116],"Dementia, Mixed","Dementia, Vascular","Dementia of Alzheimer Type","Cognitive Decline","White Matter Hyperintensity","Neuro-Degenerative Disease",[55],{"trials":119,"activeCount":96},[],{"intervention":45,"totalTrials":92,"cells":121},{"EARLY_PHASE1":122,"PHASE1":124,"PHASE2":126,"PHASE3":128,"PHASE4":130,"NA":142},{"trials":123,"activeCount":96},[],{"trials":125,"activeCount":96},[],{"trials":127,"activeCount":96},[],{"trials":129,"activeCount":96},[],{"trials":131,"activeCount":92,"soonestReadout":44},[132],{"nctId":42,"briefTitle":43,"status":106,"phases":133,"primaryCompletion":44,"completion":44,"start":134,"enrollment":135,"conditions":136,"interventions":141},[88],"2015-07",9971,[137,138,139,140],"Independent Living","Disability Free Survival","Elderly","Healthy",[45],{"trials":143,"activeCount":96},[],{"intervention":145,"totalTrials":92,"cells":146},"Liberal inspired oxygen",{"EARLY_PHASE1":147,"PHASE1":149,"PHASE2":151,"PHASE3":153,"PHASE4":155,"NA":174},{"trials":148,"activeCount":96},[],{"trials":150,"activeCount":96},[],{"trials":152,"activeCount":96},[],{"trials":154,"activeCount":96},[],{"trials":156,"activeCount":92,"soonestReadout":162},[157],{"nctId":158,"briefTitle":159,"status":160,"phases":161,"primaryCompletion":162,"completion":162,"start":163,"enrollment":164,"conditions":165,"interventions":171},"NCT07186634","PeRiOperative Medicine Platform Trial","RECRUITING",[88],"2035-12","2026-04-06",7800,[166,167,168,169,170],"Surgical Site Infection After Major Surgery","Anaesthesia","Major Complications","Quality of Recovery (QoR-15)","Quality of Life",[145,172,173],"Conservative inspired oxygen","Intermediate inspired oxygen",{"trials":175,"activeCount":96},[],{"intervention":172,"totalTrials":92,"cells":177},{"EARLY_PHASE1":178,"PHASE1":180,"PHASE2":182,"PHASE3":184,"PHASE4":186,"NA":192},{"trials":179,"activeCount":96},[],{"trials":181,"activeCount":96},[],{"trials":183,"activeCount":96},[],{"trials":185,"activeCount":96},[],{"trials":187,"activeCount":92,"soonestReadout":162},[188],{"nctId":158,"briefTitle":159,"status":160,"phases":189,"primaryCompletion":162,"completion":162,"start":163,"enrollment":164,"conditions":190,"interventions":191},[88],[166,167,168,169,170],[145,172,173],{"trials":193,"activeCount":96},[],{"intervention":173,"totalTrials":92,"cells":195},{"EARLY_PHASE1":196,"PHASE1":198,"PHASE2":200,"PHASE3":202,"PHASE4":204,"NA":210},{"trials":197,"activeCount":96},[],{"trials":199,"activeCount":96},[],{"trials":201,"activeCount":96},[],{"trials":203,"activeCount":96},[],{"trials":205,"activeCount":92,"soonestReadout":162},[206],{"nctId":158,"briefTitle":159,"status":160,"phases":207,"primaryCompletion":162,"completion":162,"start":163,"enrollment":164,"conditions":208,"interventions":209},[88],[166,167,168,169,170],[145,172,173],{"trials":211,"activeCount":96},[],{"intervention":213,"totalTrials":92,"cells":214},"Cefazolin",{"EARLY_PHASE1":215,"PHASE1":217,"PHASE2":219,"PHASE3":221,"PHASE4":223,"NA":237},{"trials":216,"activeCount":96},[],{"trials":218,"activeCount":96},[],{"trials":220,"activeCount":96},[],{"trials":222,"activeCount":96},[],{"trials":224,"activeCount":92,"soonestReadout":229},[225],{"nctId":226,"briefTitle":227,"status":160,"phases":228,"primaryCompletion":229,"completion":230,"start":231,"enrollment":232,"conditions":233,"interventions":235},"NCT05447559","Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study",[88],"2027-12","2028-06","2023-02-07",9180,[234],"Surgical Site Infection",[213,236],"Water for",{"trials":238,"activeCount":96},[],{"intervention":236,"totalTrials":92,"cells":240},{"EARLY_PHASE1":241,"PHASE1":243,"PHASE2":245,"PHASE3":247,"PHASE4":249,"NA":255},{"trials":242,"activeCount":96},[],{"trials":244,"activeCount":96},[],{"trials":246,"activeCount":96},[],{"trials":248,"activeCount":96},[],{"trials":250,"activeCount":92,"soonestReadout":229},[251],{"nctId":226,"briefTitle":227,"status":160,"phases":252,"primaryCompletion":229,"completion":230,"start":231,"enrollment":232,"conditions":253,"interventions":254},[88],[234],[213,236],{"trials":256,"activeCount":96},[],{"intervention":60,"totalTrials":25,"cells":258},{"EARLY_PHASE1":259,"PHASE1":261,"PHASE2":263,"PHASE3":265,"PHASE4":284,"NA":286},{"trials":260,"activeCount":96},[],{"trials":262,"activeCount":96},[],{"trials":264,"activeCount":96},[],{"trials":266,"activeCount":25,"soonestReadout":59},[267,273,279],{"nctId":57,"briefTitle":58,"status":160,"phases":268,"primaryCompletion":59,"completion":59,"start":269,"enrollment":270,"conditions":271,"interventions":272},[86,87],"2025-04-28",900,[19,24,22],[60],{"nctId":62,"briefTitle":63,"status":160,"phases":274,"primaryCompletion":59,"completion":59,"start":275,"enrollment":270,"conditions":276,"interventions":277},[86,87],"2025-05-06",[19,22,24],[64,278,60],"Amoxycillin\u002Fclavulanic acid",{"nctId":70,"briefTitle":71,"status":160,"phases":280,"primaryCompletion":59,"completion":59,"start":281,"enrollment":270,"conditions":282,"interventions":283},[86,87],"2025-05-07",[19,24,22],[72,60],{"trials":285,"activeCount":96},[],{"trials":287,"activeCount":96},[],{"intervention":72,"totalTrials":32,"cells":289},{"EARLY_PHASE1":290,"PHASE1":292,"PHASE2":294,"PHASE3":296,"PHASE4":308,"NA":310},{"trials":291,"activeCount":96},[],{"trials":293,"activeCount":96},[],{"trials":295,"activeCount":96},[],{"trials":297,"activeCount":32,"soonestReadout":59},[298,304],{"nctId":66,"briefTitle":67,"status":160,"phases":299,"primaryCompletion":59,"completion":59,"start":275,"enrollment":270,"conditions":300,"interventions":302},[86,87],[19,301,22],"Non-Hodgkin's Lymphoma",[68,72,303,68],"Amoxicillin clavulanic acid",{"nctId":70,"briefTitle":71,"status":160,"phases":305,"primaryCompletion":59,"completion":59,"start":281,"enrollment":270,"conditions":306,"interventions":307},[86,87],[19,24,22],[72,60],{"trials":309,"activeCount":96},[],{"trials":311,"activeCount":96},[],{"intervention":50,"totalTrials":92,"cells":313},{"EARLY_PHASE1":314,"PHASE1":316,"PHASE2":318,"PHASE3":320,"PHASE4":336,"NA":338},{"trials":315,"activeCount":96},[],{"trials":317,"activeCount":96},[],{"trials":319,"activeCount":96},[],{"trials":321,"activeCount":92,"soonestReadout":49},[322],{"nctId":47,"briefTitle":48,"status":106,"phases":323,"primaryCompletion":49,"completion":324,"start":325,"enrollment":326,"conditions":327,"interventions":334},[87],"2026-12-31","2022-12-01",960,[328,329,330,331,332,333],"HIV","Organ Transplantation","Lymphoma, Non-Hodgkin","Chronic Lymphocytic Leukemia","Multiple Myeloma","COVID-19 Vaccines",[50,335],"Moderna Bivalent mRNA vaccine",{"trials":337,"activeCount":96},[],{"trials":339,"activeCount":96},[],{"intervention":335,"totalTrials":92,"cells":341},{"EARLY_PHASE1":342,"PHASE1":344,"PHASE2":346,"PHASE3":348,"PHASE4":354,"NA":356},{"trials":343,"activeCount":96},[],{"trials":345,"activeCount":96},[],{"trials":347,"activeCount":96},[],{"trials":349,"activeCount":92,"soonestReadout":49},[350],{"nctId":47,"briefTitle":48,"status":106,"phases":351,"primaryCompletion":49,"completion":324,"start":325,"enrollment":326,"conditions":352,"interventions":353},[87],[328,329,330,331,332,333],[50,335],{"trials":355,"activeCount":96},[],{"trials":357,"activeCount":96},[],{"intervention":64,"totalTrials":92,"cells":359},{"EARLY_PHASE1":360,"PHASE1":362,"PHASE2":364,"PHASE3":366,"PHASE4":372,"NA":374},{"trials":361,"activeCount":96},[],{"trials":363,"activeCount":96},[],{"trials":365,"activeCount":96},[],{"trials":367,"activeCount":92,"soonestReadout":59},[368],{"nctId":62,"briefTitle":63,"status":160,"phases":369,"primaryCompletion":59,"completion":59,"start":275,"enrollment":270,"conditions":370,"interventions":371},[86,87],[19,22,24],[64,278,60],{"trials":373,"activeCount":96},[],{"trials":375,"activeCount":96},[],{"intervention":278,"totalTrials":92,"cells":377},{"EARLY_PHASE1":378,"PHASE1":380,"PHASE2":382,"PHASE3":384,"PHASE4":390,"NA":392},{"trials":379,"activeCount":96},[],{"trials":381,"activeCount":96},[],{"trials":383,"activeCount":96},[],{"trials":385,"activeCount":92,"soonestReadout":59},[386],{"nctId":62,"briefTitle":63,"status":160,"phases":387,"primaryCompletion":59,"completion":59,"start":275,"enrollment":270,"conditions":388,"interventions":389},[86,87],[19,22,24],[64,278,60],{"trials":391,"activeCount":96},[],{"trials":393,"activeCount":96},[],{"intervention":395,"totalTrials":92,"cells":396},"lidocaine 2% and 10%",{"EARLY_PHASE1":397,"PHASE1":399,"PHASE2":401,"PHASE3":403,"PHASE4":419,"NA":421},{"trials":398,"activeCount":96},[],{"trials":400,"activeCount":96},[],{"trials":402,"activeCount":96},[],{"trials":404,"activeCount":92,"soonestReadout":409},[405],{"nctId":406,"briefTitle":407,"status":160,"phases":408,"primaryCompletion":409,"completion":410,"start":411,"enrollment":412,"conditions":413,"interventions":418},"NCT05072314","Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial",[87],"2027-07","2028-07","2022-07-27",4300,[414,415,416,417],"Breast Cancer","Breast Cancer Female","Breast Conserving Surgery","Mastectomy",[395],{"trials":420,"activeCount":96},[],{"trials":422,"activeCount":96},[],{"intervention":82,"totalTrials":92,"cells":424},{"EARLY_PHASE1":425,"PHASE1":427,"PHASE2":429,"PHASE3":431,"PHASE4":442,"NA":444},{"trials":426,"activeCount":96},[],{"trials":428,"activeCount":96},[],{"trials":430,"activeCount":96},[],{"trials":432,"activeCount":92,"soonestReadout":81},[433],{"nctId":79,"briefTitle":80,"status":160,"phases":434,"primaryCompletion":81,"completion":81,"start":435,"enrollment":436,"conditions":437,"interventions":441},[87],"2019-05-29",336,[438,439,440],"Fetal Growth Retardation","Stillbirth and Fetal Death","Pregnancy Preterm",[82],{"trials":443,"activeCount":96},[],{"trials":445,"activeCount":96},[],{"intervention":68,"totalTrials":92,"cells":447},{"EARLY_PHASE1":448,"PHASE1":450,"PHASE2":452,"PHASE3":454,"PHASE4":460,"NA":462},{"trials":449,"activeCount":96},[],{"trials":451,"activeCount":96},[],{"trials":453,"activeCount":96},[],{"trials":455,"activeCount":92,"soonestReadout":59},[456],{"nctId":66,"briefTitle":67,"status":160,"phases":457,"primaryCompletion":59,"completion":59,"start":275,"enrollment":270,"conditions":458,"interventions":459},[86,87],[19,301,22],[68,72,303,68],{"trials":461,"activeCount":96},[],{"trials":463,"activeCount":96},[],{"intervention":303,"totalTrials":92,"cells":465},{"EARLY_PHASE1":466,"PHASE1":468,"PHASE2":470,"PHASE3":472,"PHASE4":478,"NA":480},{"trials":467,"activeCount":96},[],{"trials":469,"activeCount":96},[],{"trials":471,"activeCount":96},[],{"trials":473,"activeCount":92,"soonestReadout":59},[474],{"nctId":66,"briefTitle":67,"status":160,"phases":475,"primaryCompletion":59,"completion":59,"start":275,"enrollment":270,"conditions":476,"interventions":477},[86,87],[19,301,22],[68,72,303,68],{"trials":479,"activeCount":96},[],{"trials":481,"activeCount":96},[],{"intervention":77,"totalTrials":92,"cells":483},{"EARLY_PHASE1":484,"PHASE1":486,"PHASE2":488,"PHASE3":490,"PHASE4":502,"NA":504},{"trials":485,"activeCount":96},[],{"trials":487,"activeCount":96},[],{"trials":489,"activeCount":96},[],{"trials":491,"activeCount":92,"soonestReadout":76},[492],{"nctId":74,"briefTitle":75,"status":160,"phases":493,"primaryCompletion":76,"completion":76,"start":494,"enrollment":495,"conditions":496,"interventions":499},[86,87],"2022-11-30",300,[497,498],"Haematological Malignancy","Hypogammaglobulinemia",[77,500,501],"amoxycillin\u002Fclavulanic acid and ciprofloxacin","Immunoglobulins",{"trials":503,"activeCount":96},[],{"trials":505,"activeCount":96},[],{"intervention":500,"totalTrials":92,"cells":507},{"EARLY_PHASE1":508,"PHASE1":510,"PHASE2":512,"PHASE3":514,"PHASE4":520,"NA":522},{"trials":509,"activeCount":96},[],{"trials":511,"activeCount":96},[],{"trials":513,"activeCount":96},[],{"trials":515,"activeCount":92,"soonestReadout":76},[516],{"nctId":74,"briefTitle":75,"status":160,"phases":517,"primaryCompletion":76,"completion":76,"start":494,"enrollment":495,"conditions":518,"interventions":519},[86,87],[497,498],[77,500,501],{"trials":521,"activeCount":96},[],{"trials":523,"activeCount":96},[],{"intervention":501,"totalTrials":92,"cells":525},{"EARLY_PHASE1":526,"PHASE1":528,"PHASE2":530,"PHASE3":532,"PHASE4":538,"NA":540},{"trials":527,"activeCount":96},[],{"trials":529,"activeCount":96},[],{"trials":531,"activeCount":96},[],{"trials":533,"activeCount":92,"soonestReadout":76},[534],{"nctId":74,"briefTitle":75,"status":160,"phases":535,"primaryCompletion":76,"completion":76,"start":494,"enrollment":495,"conditions":536,"interventions":537},[86,87],[497,498],[77,500,501],{"trials":539,"activeCount":96},[],{"trials":541,"activeCount":96},[],{"intervention":543,"totalTrials":92,"cells":544},"STX-1150",{"EARLY_PHASE1":545,"PHASE1":547,"PHASE2":560,"PHASE3":562,"PHASE4":564,"NA":566},{"trials":546,"activeCount":96},[],{"trials":548,"activeCount":92,"soonestReadout":554},[549],{"nctId":550,"briefTitle":551,"status":552,"phases":553,"primaryCompletion":554,"completion":554,"start":555,"enrollment":556,"conditions":557,"interventions":559},"NCT07428473","A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)","NOT_YET_RECRUITING",[85],"2028-12-30","2026-06-01",64,[558],"Elevated LDL-C and High Cholesterol",[543],{"trials":561,"activeCount":96},[],{"trials":563,"activeCount":96},[],{"trials":565,"activeCount":96},[],{"trials":567,"activeCount":96},[],{"intervention":40,"totalTrials":92,"cells":569},{"EARLY_PHASE1":570,"PHASE1":572,"PHASE2":574,"PHASE3":576,"PHASE4":578,"NA":580},{"trials":571,"activeCount":96},[],{"trials":573,"activeCount":96},[],{"trials":575,"activeCount":96},[],{"trials":577,"activeCount":96},[],{"trials":579,"activeCount":96},[],{"trials":581,"activeCount":92,"soonestReadout":39},[582],{"nctId":37,"briefTitle":38,"status":583,"phases":584,"primaryCompletion":39,"completion":585,"start":586,"enrollment":587,"conditions":588,"interventions":591},"ENROLLING_BY_INVITATION",[],"2026-07-11","2020-09-25",323,[589,590],"Multiple Sclerosis","Adherence, Medication",[40,592,593,594,595,596],"Dimethyl fumarate","Fingolimod","Teriflunomide","Ozanimod","Diroximel fumarate",{"intervention":592,"totalTrials":92,"cells":598},{"EARLY_PHASE1":599,"PHASE1":601,"PHASE2":603,"PHASE3":605,"PHASE4":607,"NA":609},{"trials":600,"activeCount":96},[],{"trials":602,"activeCount":96},[],{"trials":604,"activeCount":96},[],{"trials":606,"activeCount":96},[],{"trials":608,"activeCount":96},[],{"trials":610,"activeCount":92,"soonestReadout":39},[611],{"nctId":37,"briefTitle":38,"status":583,"phases":612,"primaryCompletion":39,"completion":585,"start":586,"enrollment":587,"conditions":613,"interventions":614},[],[589,590],[40,592,593,594,595,596],{"intervention":593,"totalTrials":92,"cells":616},{"EARLY_PHASE1":617,"PHASE1":619,"PHASE2":621,"PHASE3":623,"PHASE4":625,"NA":627},{"trials":618,"activeCount":96},[],{"trials":620,"activeCount":96},[],{"trials":622,"activeCount":96},[],{"trials":624,"activeCount":96},[],{"trials":626,"activeCount":96},[],{"trials":628,"activeCount":92,"soonestReadout":39},[629],{"nctId":37,"briefTitle":38,"status":583,"phases":630,"primaryCompletion":39,"completion":585,"start":586,"enrollment":587,"conditions":631,"interventions":632},[],[589,590],[40,592,593,594,595,596],{"intervention":594,"totalTrials":92,"cells":634},{"EARLY_PHASE1":635,"PHASE1":637,"PHASE2":639,"PHASE3":641,"PHASE4":643,"NA":645},{"trials":636,"activeCount":96},[],{"trials":638,"activeCount":96},[],{"trials":640,"activeCount":96},[],{"trials":642,"activeCount":96},[],{"trials":644,"activeCount":96},[],{"trials":646,"activeCount":92,"soonestReadout":39},[647],{"nctId":37,"briefTitle":38,"status":583,"phases":648,"primaryCompletion":39,"completion":585,"start":586,"enrollment":587,"conditions":649,"interventions":650},[],[589,590],[40,592,593,594,595,596],{"intervention":595,"totalTrials":92,"cells":652},{"EARLY_PHASE1":653,"PHASE1":655,"PHASE2":657,"PHASE3":659,"PHASE4":661,"NA":663},{"trials":654,"activeCount":96},[],{"trials":656,"activeCount":96},[],{"trials":658,"activeCount":96},[],{"trials":660,"activeCount":96},[],{"trials":662,"activeCount":96},[],{"trials":664,"activeCount":92,"soonestReadout":39},[665],{"nctId":37,"briefTitle":38,"status":583,"phases":666,"primaryCompletion":39,"completion":585,"start":586,"enrollment":587,"conditions":667,"interventions":668},[],[589,590],[40,592,593,594,595,596],{"intervention":596,"totalTrials":92,"cells":670},{"EARLY_PHASE1":671,"PHASE1":673,"PHASE2":675,"PHASE3":677,"PHASE4":679,"NA":681},{"trials":672,"activeCount":96},[],{"trials":674,"activeCount":96},[],{"trials":676,"activeCount":96},[],{"trials":678,"activeCount":96},[],{"trials":680,"activeCount":96},[],{"trials":682,"activeCount":92,"soonestReadout":39},[683],{"nctId":37,"briefTitle":38,"status":583,"phases":684,"primaryCompletion":39,"completion":585,"start":586,"enrollment":587,"conditions":685,"interventions":686},[],[589,590],[40,592,593,594,595,596],{"intervention":688,"totalTrials":92,"cells":689},"Perindopril",{"EARLY_PHASE1":690,"PHASE1":692,"PHASE2":694,"PHASE3":696,"PHASE4":698,"NA":710},{"trials":691,"activeCount":96},[],{"trials":693,"activeCount":96},[],{"trials":695,"activeCount":96},[],{"trials":697,"activeCount":96},[],{"trials":699,"activeCount":96},[700],{"nctId":701,"briefTitle":702,"status":703,"phases":704,"enrollment":96,"conditions":705,"interventions":707},"NCT01089452","Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study","WITHDRAWN",[88],[706],"Hypertension",[688,708,709],"Perindopril\u002Famlodipine","Olmesartan\u002Famlodipine",{"trials":711,"activeCount":96},[],{"intervention":708,"totalTrials":92,"cells":713},{"EARLY_PHASE1":714,"PHASE1":716,"PHASE2":718,"PHASE3":720,"PHASE4":722,"NA":728},{"trials":715,"activeCount":96},[],{"trials":717,"activeCount":96},[],{"trials":719,"activeCount":96},[],{"trials":721,"activeCount":96},[],{"trials":723,"activeCount":96},[724],{"nctId":701,"briefTitle":702,"status":703,"phases":725,"enrollment":96,"conditions":726,"interventions":727},[88],[706],[688,708,709],{"trials":729,"activeCount":96},[],{"intervention":709,"totalTrials":92,"cells":731},{"EARLY_PHASE1":732,"PHASE1":734,"PHASE2":736,"PHASE3":738,"PHASE4":740,"NA":746},{"trials":733,"activeCount":96},[],{"trials":735,"activeCount":96},[],{"trials":737,"activeCount":96},[],{"trials":739,"activeCount":96},[],{"trials":741,"activeCount":96},[742],{"nctId":701,"briefTitle":702,"status":703,"phases":743,"enrollment":96,"conditions":744,"interventions":745},[88],[706],[688,708,709],{"trials":747,"activeCount":96},[],{"intervention":749,"totalTrials":92,"cells":750},"Alendronate",{"EARLY_PHASE1":751,"PHASE1":753,"PHASE2":755,"PHASE3":757,"PHASE4":759,"NA":773},{"trials":752,"activeCount":96},[],{"trials":754,"activeCount":96},[],{"trials":756,"activeCount":96},[],{"trials":758,"activeCount":96},[],{"trials":760,"activeCount":96},[761],{"nctId":762,"briefTitle":763,"status":764,"phases":765,"primaryCompletion":766,"completion":766,"start":767,"enrollment":768,"conditions":769,"interventions":772},"NCT00395382","Study of the Effect of Alendronate on Vascular Calcification and Arterial Stiffness in Chronic Kidney Disease","COMPLETED",[88],"2009-09","2007-01",50,[770,771],"Vascular Calcification","Arteriosclerosis",[749],{"trials":774,"activeCount":96},[],{"intervention":776,"totalTrials":92,"cells":777},"Melatonin",{"EARLY_PHASE1":778,"PHASE1":780,"PHASE2":782,"PHASE3":784,"PHASE4":786,"NA":798},{"trials":779,"activeCount":96},[],{"trials":781,"activeCount":96},[],{"trials":783,"activeCount":96},[],{"trials":785,"activeCount":96},[],{"trials":787,"activeCount":96},[788],{"nctId":789,"briefTitle":790,"status":764,"phases":791,"primaryCompletion":792,"completion":793,"start":794,"enrollment":795,"conditions":796,"interventions":797},"NCT01695070","Melatonin to Prevent Brain Injury in Unborn Growth Restricted Babies",[88],"2014-10","2014-11","2012-09",16,[438],[776],{"trials":799,"activeCount":96},[],{"intervention":801,"totalTrials":92,"cells":802},"Tranexamic Acid",{"EARLY_PHASE1":803,"PHASE1":805,"PHASE2":807,"PHASE3":809,"PHASE4":823,"NA":825},{"trials":804,"activeCount":96},[],{"trials":806,"activeCount":96},[],{"trials":808,"activeCount":96},[],{"trials":810,"activeCount":96},[811],{"nctId":812,"briefTitle":813,"status":764,"phases":814,"primaryCompletion":815,"completion":816,"start":817,"enrollment":818,"conditions":819,"interventions":822},"NCT02187120","Pre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study)",[87],"2022-05-09","2022-09-07","2014-07-28",1310,[820,821],"Wounds and Injuries","Acute Coagulopathy",[801],{"trials":824,"activeCount":96},[],{"trials":826,"activeCount":96},[],{"intervention":828,"totalTrials":92,"cells":829},"Spironolactone",{"EARLY_PHASE1":830,"PHASE1":832,"PHASE2":834,"PHASE3":836,"PHASE4":848,"NA":850},{"trials":831,"activeCount":96},[],{"trials":833,"activeCount":96},[],{"trials":835,"activeCount":96},[],{"trials":837,"activeCount":96},[838],{"nctId":839,"briefTitle":840,"status":764,"phases":841,"primaryCompletion":842,"completion":843,"start":844,"enrollment":845,"conditions":846,"interventions":847},"NCT00604006","SCREEN-HFI (SCReening Evaluation of the Evolution of New Heart Failure Intervention Study)",[87],"2014-08","2015-01","2008-09",20,[16],[828],{"trials":849,"activeCount":96},[],{"trials":851,"activeCount":96},[],{"intervention":853,"totalTrials":92,"cells":854},"dehydroepiandrosterone",{"EARLY_PHASE1":855,"PHASE1":857,"PHASE2":859,"PHASE3":861,"PHASE4":874,"NA":876},{"trials":856,"activeCount":96},[],{"trials":858,"activeCount":96},[],{"trials":860,"activeCount":96},[],{"trials":862,"activeCount":96},[863],{"nctId":864,"briefTitle":865,"status":764,"phases":866,"primaryCompletion":867,"completion":867,"start":868,"enrollment":869,"conditions":870,"interventions":873},"NCT00289926","Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms",[87],"2008-04","2006-02",240,[170,871,872],"Menopausal Syndrome","Libido Disorder",[853],{"trials":875,"activeCount":96},[],{"trials":877,"activeCount":96},[],{"intervention":879,"totalTrials":92,"cells":880},"Oxygen",{"EARLY_PHASE1":881,"PHASE1":883,"PHASE2":885,"PHASE3":896,"PHASE4":898,"NA":900},{"trials":882,"activeCount":96},[],{"trials":884,"activeCount":96},[],{"trials":886,"activeCount":96},[887],{"nctId":888,"briefTitle":889,"status":764,"phases":890,"primaryCompletion":891,"completion":891,"start":134,"enrollment":892,"conditions":893,"interventions":895},"NCT02499042","rEduction of oXygen After Cardiac arresT: a Pilot Study",[86],"2017-08",59,[894],"Heart Arrest",[879],{"trials":897,"activeCount":96},[],{"trials":899,"activeCount":96},[],{"trials":901,"activeCount":96},[],{"intervention":903,"totalTrials":92,"cells":904},"Urotensine II",{"EARLY_PHASE1":905,"PHASE1":907,"PHASE2":909,"PHASE3":920,"PHASE4":922,"NA":924},{"trials":906,"activeCount":96},[],{"trials":908,"activeCount":96},[],{"trials":910,"activeCount":96},[911],{"nctId":912,"briefTitle":913,"status":764,"phases":914,"primaryCompletion":915,"completion":915,"start":916,"enrollment":795,"conditions":917,"interventions":918},"NCT00654966","Evaluation of the Effects of Urotensin-II and Soluble Epoxide Hydrolase Inhibitors on Skin Microvessel Tone in Patients With Heart Failure, and in Healthy Volunteers",[86],"2010-12","2009-06",[16],[903,919],"Soluble epoxide hydrolase",{"trials":921,"activeCount":96},[],{"trials":923,"activeCount":96},[],{"trials":925,"activeCount":96},[],{"intervention":919,"totalTrials":92,"cells":927},{"EARLY_PHASE1":928,"PHASE1":930,"PHASE2":932,"PHASE3":938,"PHASE4":940,"NA":942},{"trials":929,"activeCount":96},[],{"trials":931,"activeCount":96},[],{"trials":933,"activeCount":96},[934],{"nctId":912,"briefTitle":913,"status":764,"phases":935,"primaryCompletion":915,"completion":915,"start":916,"enrollment":795,"conditions":936,"interventions":937},[86],[16],[903,919],{"trials":939,"activeCount":96},[],{"trials":941,"activeCount":96},[],{"trials":943,"activeCount":96},[],{"intervention":945,"totalTrials":92,"cells":946},"Carnosine",{"EARLY_PHASE1":947,"PHASE1":949,"PHASE2":951,"PHASE3":964,"PHASE4":966,"NA":968},{"trials":948,"activeCount":96},[],{"trials":950,"activeCount":96},[],{"trials":952,"activeCount":96},[953],{"nctId":954,"briefTitle":955,"status":956,"phases":957,"primaryCompletion":958,"completion":958,"start":959,"enrollment":960,"conditions":961,"interventions":963},"NCT03844113","Carnosine for Peripheral Vascular Disease","UNKNOWN",[86],"2022-12-31","2019-03-01",104,[962],"Peripheral Arterial Disease",[945],{"trials":965,"activeCount":96},[],{"trials":967,"activeCount":96},[],{"trials":969,"activeCount":96},[],{"intervention":971,"totalTrials":92,"cells":972},"Linagliptin",{"EARLY_PHASE1":973,"PHASE1":975,"PHASE2":988,"PHASE3":990,"PHASE4":992,"NA":994},{"trials":974,"activeCount":96},[],{"trials":976,"activeCount":96},[977],{"nctId":978,"briefTitle":979,"status":980,"phases":981,"primaryCompletion":982,"completion":983,"start":984,"enrollment":92,"conditions":985,"interventions":987},"NCT01943019","Linagliptin in Schizophrenia Patients","TERMINATED",[85],"2018-07","2018-08","2013-08",[986],"Schizophrenia",[971],{"trials":989,"activeCount":96},[],{"trials":991,"activeCount":96},[],{"trials":993,"activeCount":96},[],{"trials":995,"activeCount":96},[],{"intervention":997,"totalTrials":92,"cells":998},"aromatase inhibitors",{"EARLY_PHASE1":999,"PHASE1":1001,"PHASE2":1003,"PHASE3":1005,"PHASE4":1007,"NA":1009},{"trials":1000,"activeCount":96},[],{"trials":1002,"activeCount":96},[],{"trials":1004,"activeCount":96},[],{"trials":1006,"activeCount":96},[],{"trials":1008,"activeCount":96},[],{"trials":1010,"activeCount":96},[1011],{"nctId":1012,"briefTitle":1013,"status":764,"phases":1014,"primaryCompletion":1015,"completion":1016,"start":1017,"enrollment":1018,"conditions":1019,"interventions":1021},"NCT00111241","Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors",[],"2011-05","2011-12","2005-05",115,[1020],"Arthralgia",[997],{"intervention":1023,"totalTrials":92,"cells":1024},"Hydration",{"EARLY_PHASE1":1025,"PHASE1":1027,"PHASE2":1029,"PHASE3":1031,"PHASE4":1033,"NA":1035},{"trials":1026,"activeCount":96},[],{"trials":1028,"activeCount":96},[],{"trials":1030,"activeCount":96},[],{"trials":1032,"activeCount":96},[],{"trials":1034,"activeCount":96},[],{"trials":1036,"activeCount":96},[1037],{"nctId":1038,"briefTitle":1039,"status":764,"phases":1040,"primaryCompletion":1041,"completion":1041,"start":1042,"enrollment":1043,"conditions":1044,"interventions":1046},"NCT01852669","Adjunct Inversion for Lower Pole Stone",[89],"2008-12","2002-01",140,[1045],"Kidney Stone",[1023],{"intervention":1048,"totalTrials":92,"cells":1049},"metronidazole and cephalzolin",{"EARLY_PHASE1":1050,"PHASE1":1052,"PHASE2":1054,"PHASE3":1056,"PHASE4":1058,"NA":1060},{"trials":1051,"activeCount":96},[],{"trials":1053,"activeCount":96},[],{"trials":1055,"activeCount":96},[],{"trials":1057,"activeCount":96},[],{"trials":1059,"activeCount":96},[],{"trials":1061,"activeCount":96},[1062],{"nctId":1063,"briefTitle":1064,"status":764,"phases":1065,"primaryCompletion":1066,"completion":1067,"start":1068,"enrollment":495,"conditions":1069,"interventions":1071},"NCT01420367","Are Post-operative Antibiotics Indicated in Simple Appendicitis?",[89],"2013-11","2013-12","2011-11",[1070],"Appendicitis",[1048]]